Liquid Dosage
Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.
As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.
Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.
A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.
As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.
Отображение 4 из 12

GEA Hilge offers a versatile range of centrifugal and positive displacement pumps for a wide variety of sensitive applications in the beverage, food and pharmaceutical industries.

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

Every plant or machine, which is designed for a reliable long-term operation, requires a control unit that enables the communication between the different system parts. It is one of the most important component that guarantees reliability and efficient operation.

Компрессионные головки компании GEA являются сердцем гомогенизатора, так как они запускают процесс гомогенизации, перекачивая продукт под высоким давлением, пока он не попадет в гомогенизирующий клапан.

Новый Центр передовых технологий GEA Application and Technology Center (ATC) в Сарштедте, к югу от Ганновера, не является ни выставочным залом, ни аналогом лаборатории. Это место для тестирования, сбора данных и принятия предварительных решений. Именно здесь становится ясно, сможет ли биологическая концепция превратиться в надежный производственный процесс. Значение этого этапа намного важнее, чем это может казаться.

Термоформование уже давно играет центральную роль в сфере упаковки пищевых продуктов. Сейчас это направление переживает серьезные перемены. В условиях ужесточения нормативных требований, а также по мере разработки новых материалов и роста затрат производственные линии формования, наполнения и запайки должны не только обеспечивать надежную работу — теперь они определяют, насколько продукты питания остаются свежими и доступными по цене, а упаковка пригодной для вторичной переработки. Познакомьтесь с основными тенденциями в области термоформования, определяющими развитие рынка упаковки и поставки продуктов питания.